The latter shows downstream effects affecting both tumor proliferation and invasiveness (Fig. 9c), further causing the activation of CTNNB1 and MYC, and inducing the maintenance of active cyclins (CCND1 and CCNE1) (Fig. 9b, c). The gene discussed is CTNNB1; the disease is neoplasm.